Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

Matched clinical trials

  • Study on the Effects of Amikacin Liposome Inhalation, Azithromycin, and Ethambutol in Adults with Newly Diagnosed Nontuberculous Mycobacterial Lung Infection

    Not recruiting

    1 1 1
    Austria Belgium Denmark France Germany Greece +5
  • Study on the Safety and Effects of Mosunetuzumab and Lenalidomide for Patients with Follicular Lymphoma

    Not recruiting

    1 1 1
    Investigated diseases:
    France Spain
  • Study Comparing Subcutaneous and Intravenous Isatuximab with Pomalidomide and Dexamethasone for Adults with Relapsed or Refractory Multiple Myeloma

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Czechia France Germany Greece Hungary Italy +4
  • Study on the Long-Term Safety of Povorcitinib for Patients with Moderate to Severe Hidradenitis Suppurativa

    Not recruiting

    1 1 1
    Austria Belgium Bulgaria Czechia Denmark France +6
  • Study on the Safety and Effectiveness of Epcoritamab, Venetoclax, and Lenalidomide for Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia and Richter’s Syndrome

    Not recruiting

    1 1 1
    Belgium Czechia Denmark France Germany Italy +3
  • Study on the Safety and Effectiveness of Tovinontrine for Adults with Chronic Heart Failure with Reduced Ejection Fraction

    Not recruiting

    Investigated drugs:
    Belgium Bulgaria Czechia Germany Hungary Italy +6
  • Study on the Effects of Mepolizumab for Achieving Clinical Remission in Patients with Severe Asthma

    Not recruiting

    1 1 1 1
    Investigated drugs:
    Belgium France Germany Italy Poland Spain
  • Study on the Effects of Ezabenlimab and BI 907828 in Adult Patients with Advanced or Metastatic Solid Tumors

    Not recruiting

    1 1
    France
  • Study on Rivaroxaban, Dabigatran Etexilate, and Fluindione for Patients with Intra-Cardiac Thrombus

    Not recruiting

    1 1 1 1
    France
  • Study Comparing ACP-196 and Ibrutinib for Patients with High-Risk Chronic Lymphocytic Leukemia

    Not recruiting

    1 1 1 1
    Investigated drugs:
    Poland Spain